Phase 1 Primary Biliary Cholangitis Trial, Recruiting (NCT02137668)

Phase 1 Primary Biliary Cholangitis Trial, Recruiting NCT02137668 Sponsor: Sacramento Pediatric Gastroenterology Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT02137668 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with primary sclerosing cholangitis (a liver and bile duct condition), biliary atresia (a bile duct condition present from birth), a long-term intestinal disorder, or you are scheduled to have a camera examination of your upper or lower digestive tract (endoscopy).
You have primary sclerosing cholangitis or biliary atresia and your doctor considers you a suitable candidate for treatment with the antibiotic vancomycin.

Who may not be able to join:

You have taken antibiotics or medicines that affect the immune system within the last 3 months, as these can change the natural bacteria in your gut.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02137668

Sponsor: Sacramento Pediatric Gastroenterology

Phase: Phase 1

Status: Recruiting

Condition: Primary Biliary Cholangitis

More information: https://clinicaltrials.gov/study/NCT02137668

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with primary sclerosing cholangitis (a liver and bile duct condition), biliary atresia (a bile duct condition present from birth), a long-term intestinal disorder, or you are scheduled to have a camera examination of your upper or lower digestive tract (endoscopy).
You have primary sclerosing cholangitis or biliary atresia and your doctor considers you a suitable candidate for treatment with the antibiotic vancomycin.

Who may not be able to join:

You have taken antibiotics or medicines that affect the immune system within the last 3 months, as these can change the natural bacteria in your gut.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Sacramento Pediatric Gastroenterology

Registry

ClinicalTrials.gov

Start date

1 July 2010

Est. completion

1 May 2018

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Determine the benefit of oral vancomycin therapy for Primary Sclerosing Cholangitis and Biliary Atresia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov